VP301

N/A

Report date: 2023/09/22 20:07:23

Base Information

Drug NameVP301

Drug Alias NameVP-301

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > Protein drugs > Immunoglobulin

Mechanisms of ActionAnti-CD38Anti-Intercellular adhesion molecule-1

TargetsLymphocyte differentiation antigen CD38Intercellular adhesion molecule-1

Therapy Area/IndicationsSolid tumoursMultiple MyelomaLymphoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesVirtuoso BINco Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesVirtuoso BINco Inc

Active IndicationsN/A

Inactive IndicationsSolid tumoursMultiple MyelomaLymphoma

Other Information

ATC CodeN/A